Skip to main content

Advertisement

SpringerLink
Log in

Assessing and Modifying Coronary Artery Disease Risk in Women

  • Prevention (P Natarajan, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Despite continued advances in the field, cardiovascular disease remains the leading cause of death in women in the USA with an annual mortality rate that has remained higher for women as compared to men. The factors leading to this sex difference remain incompletely understood. Likely contributors include atypical symptoms at presentation and lack of recognition of cardiovascular risk by women and their providers alike. In addition, women have a higher burden of comorbidities at the time of disease diagnosis and can have differential pathophysiological mechanisms of their acute events. Women also can develop unique cardiovascular risk factors such as preeclampsia and hypertensive disorders of pregnancy. As a result, when women present with symptoms, even atypical, healthcare providers should increase their index level of suspicion for cardiovascular disease. Even after diagnosis, women are less likely to receive guideline-directed medical therapies and be referred for coronary angiography or cardiac rehabilitation. Thus, greater awareness of and research into the aspects of coronary disease that remain unique to women is critical, as women presenting with coronary disease continue to receive disparate care as compared to men. Improvements in awareness and care and new research avenues may reduce the incidence and complications of cardiovascular disease among women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association Circulation. 2016;133:916–47. The first statement on acute myocardial infarction by the American Heart Association discussing sex-specific differences in prevalence, risk factors, and treatments.

  2. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54:1561–75.

    Article  PubMed  PubMed Central  Google Scholar 

  3. •• McSweeney JC, Rosenfeld AG, Abel WM, et al. Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association. Circulation. 2016;133:1302–31. A statement by the American Heart Association on ischemic heart disease in women discussing sex-specific differences in prevalence, public awareness, symptomatology, risk factors, and diagnostic challenges.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757–67.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832–7.

    Article  PubMed  Google Scholar 

  6. Shah T, Palaskas N, Ahmed A. An update on gender disparities in coronary heart disease care. Current atherosclerosis reports. 2016;18:28.

    Article  PubMed  Google Scholar 

  7. Bjerking LH, Hansen KW, Madsen M, et al. Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a matched cohort study. BMC Cardiovasc Disord. 2016;16:120.

    Article  PubMed  PubMed Central  Google Scholar 

  8. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation. 2003;108:2619–23.

    Article  PubMed  Google Scholar 

  9. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47:S21–9.

    Article  PubMed  Google Scholar 

  10. Hwang SY, Zerwic JJ, Jeong MH. Impact of prodromal symptoms on prehospital delay in patients with first-time acute myocardial infarction in Korea. The Journal of cardiovascular nursing. 2011;26:194–201.

    Article  PubMed  Google Scholar 

  11. • D’Onofrio G, Safdar B, Lichtman JH, et al. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131:1324–32. Study of sex differences in time delays to reperfusion therapy and types of reperfusion therapy among patients presenting with ST-segment-elevation myocardial infarction.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861–70.

    Article  CAS  PubMed  Google Scholar 

  13. • Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38:143–53. Position paper by the European Society of Cardiology on myocardial infarction with non-obstructive coronary arteries.

  14. Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414–25.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ouldzein H, Elbaz M, Roncalli J, et al. Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion: analysis by intravascular ultrasound. Annales de cardiologie et d'angeiologie. 2012;61:20–6.

    Article  CAS  PubMed  Google Scholar 

  16. Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135:1075–92.

    Article  PubMed  Google Scholar 

  17. Doyle M, Weinberg N, Pohost GM, et al. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovascular imaging. 2010;3:1030–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung And Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55:2825–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Marinescu MA, Loffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovascular imaging. 2015;8:210–20.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ong P, Athanasiadis A, Sechtem U. Treatment of angina pectoris associated with coronary microvascular dysfunction. Cardiovasc Drugs Ther. 2016;30:351–6.

    Article  CAS  PubMed  Google Scholar 

  21. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.

    Article  PubMed  Google Scholar 

  22. Tweet MS, Gulati R, Hayes SN. Spontaneous coronary artery dissection. Current cardiology reports. 2016;18:60.

    Article  PubMed  Google Scholar 

  23. Vanzetto G, Berger-Coz E, Barone-Rochette G, et al. Prevalence, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection: results from a database of 11,605 patients. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2009;35:250–4.

    Article  Google Scholar 

  24. Tweet MS, Eleid MF, Best PJ, et al. Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circulation Cardiovascular interventions. 2014;7:777–86.

    Article  PubMed  Google Scholar 

  25. Tweet MS, Gulati R, Williamson EE, Vrtiska TJ, Hayes SN. Multimodality imaging for spontaneous coronary artery dissection in women. JACC Cardiovascular imaging. 2016;9:436–50.

    Article  PubMed  Google Scholar 

  26. Wood MJ, Drachman DE. Angiographic and interventional management of spontaneous coronary artery dissections: when less is more, or “when ‘better’ flow is the enemy of good flow”. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions. 2017;89:68–70.

    Article  Google Scholar 

  27. Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009;158:688–94.

    Article  PubMed  Google Scholar 

  28. Roy RR, Hurst RT, Lester SJ, et al. Risk stratification for cardiovascular disease in women in the primary care setting. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2015;28:1232–9.

    Article  Google Scholar 

  29. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–9.

    Article  CAS  PubMed  Google Scholar 

  30. Kavousi M, Desai CS, Ayers C, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016;316:2126–34.

    Article  CAS  PubMed  Google Scholar 

  31. Ferrari R, Abergel H, Ford I, et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2013;167:2938–43.

    Article  PubMed  Google Scholar 

  32. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29:932–40.

    Article  PubMed  Google Scholar 

  33. Bahler C, Gutzwiller F, Erne P, Radovanovic D. Lower age at first myocardial infarction in female compared to male smokers. Eur J Prev Cardiol. 2012;19:1184–93.

    Article  PubMed  Google Scholar 

  34. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378:1297–305.

    Article  PubMed  Google Scholar 

  35. Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation. 2014;45:1545–88.

    Article  Google Scholar 

  36. Lu HT, Nordin R, Wan Ahmad WA, et al. Sex differences in acute coronary syndrome in a multiethnic Asian population: results of the Malaysian national cardiovascular disease database-acute coronary syndrome (NCVD-ACS) registry. Glob Heart. 2014;9:381–90.

    Article  PubMed  Google Scholar 

  37. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57:1542–51.

    Article  PubMed  Google Scholar 

  38. Rossi MC, Cristofaro MR, Gentile S, et al. Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the AMD Annals initiative. Diabetes Care. 2013;36:3162–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Donahue RP, Rejman K, Rafalson LB, Dmochowski J, Stranges S, Trevisan M. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study. Diabetes Care. 2007;30:354–9.

    Article  PubMed  Google Scholar 

  40. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:597–604.

    Article  CAS  PubMed  Google Scholar 

  41. Burke AP, Farb A, Malcom G, Virmani R. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Am Heart J. 2001;141:S58–62.

    Article  CAS  PubMed  Google Scholar 

  42. Bairey Merz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41:413–9.

    Article  PubMed  Google Scholar 

  43. Davidson MH, Maki KC, Karp SK, Ingram KA. Management of hypercholesterolaemia in postmenopausal women. Drugs Aging. 2002;19:169–78.

    Article  CAS  PubMed  Google Scholar 

  44. Puri R, Nissen SE, Shao M, et al. Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. JACC Cardiovascular imaging. 2014;7:1013–22.

    Article  PubMed  Google Scholar 

  45. Virani SS, Woodard LD, Ramsey DJ, et al. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015;115:21–6.

    Article  PubMed  Google Scholar 

  46. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Mannisto T, Mendola P, Vaarasmaki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681–90.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol. 2007;3:613–22.

    Article  PubMed  Google Scholar 

  49. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172:642–8.

    Article  CAS  PubMed  Google Scholar 

  50. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol. 1998;16:41–6.

    Article  CAS  PubMed  Google Scholar 

  51. Veerbeek JH, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015;65:600–6.

    Article  CAS  PubMed  Google Scholar 

  52. Schokker SA, Van Oostwaard MF, Melman EM, et al. Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy. Pregnancy hypertension. 2015;5:287–93.

    CAS  PubMed  Google Scholar 

  53. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797–803.

    Article  PubMed  Google Scholar 

  54. •• Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–23. Updated guidelines from the American Heart Association on cardiovascular disease prevention in women.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145:408–15.

    Article  CAS  PubMed  Google Scholar 

  56. Corrales A, Dessein PH, Tsang L, et al. Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study. Arthritis research & therapy. 2015;17:55.

    Article  Google Scholar 

  57. Mosca L, Hammond G, Mochari-Greenberger H, et al. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013;127:1254–63.

  58. Leifheit-Limson EC, D'Onofrio G, Daneshvar M, et al. Sex differences in cardiac risk factors, perceived risk, and health care provider discussion of risk and risk modification among young patients with acute myocardial infarction: the VIRGO Study. J Am Coll Cardiol. 2015;66:1949–57.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–61.

    Article  CAS  PubMed  Google Scholar 

  60. Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Shah AS, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015;350:g7873.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Lyngbakken MN, Rosjo H, Holmen OL, et al. Gender, high-sensitivity troponin I, and the risk of cardiovascular events (from the Nord-Trondelag Health Study). Am J Cardiol. 2016;118:816–21.

    Article  CAS  PubMed  Google Scholar 

  63. Motiwala SR, Sarma A, Januzzi JL, O’Donoghue ML. Biomarkers in ACS and heart failure: should men and women be interpreted differently? Clin Chem. 2014;60:35–43.

    Article  CAS  PubMed  Google Scholar 

  64. Trambas C, Pickering JW, Than M, et al. Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction. Clin Chem. 2016;62:831–8.

    Article  CAS  PubMed  Google Scholar 

  65. Rubini Gimenez M, Twerenbold R, Boeddinghaus J, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA cardiology. 2016;1(8):912–20.

    Article  PubMed  Google Scholar 

  66. Mieres JH, Gulati M, Bairey Merz N, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation. 2014;130:350–79.

    Article  PubMed  Google Scholar 

  67. Morise AP, Dalal JN, Duval RD. Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med. 1993;94:491–6.

    Article  CAS  PubMed  Google Scholar 

  68. Bokhari S, Shahzad A, Bergmann SR. Superiority of exercise myocardial perfusion imaging compared with the exercise ECG in the diagnosis of coronary artery disease. Coron Artery Dis. 2008;19:399–404.

    Article  PubMed  Google Scholar 

  69. Mieres JH, Shaw LJ, Hendel RC, et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease—the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology. 2003;10:95–101.

    Article  Google Scholar 

  70. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology. 2006;13:24–33.

    Article  Google Scholar 

  71. Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation. 2014;129:1129–38.

    Article  PubMed  Google Scholar 

  72. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948–53.

    Article  PubMed  Google Scholar 

  73. Dharampal AS, Rossi A, Papadopoulou SL, et al. Is there a difference in the diagnostic accuracy of computed tomography coronary angiography between women and men? Coron Artery Dis. 2011;22:421–7.

    Article  PubMed  Google Scholar 

  74. Jug B, Gupta M, Papazian J, et al. Diagnostic performance of 64-slice multidetector coronary computed tomographic angiography in women. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology. 2012;19:1154–61.

    Article  Google Scholar 

  75. Tsang JC, Min JK, Lin FY, Shaw LJ, Budoff MJ. Sex comparison of diagnostic accuracy of 64-multidetector row coronary computed tomographic angiography: results from the multicenter ACCURACY trial. Journal of cardiovascular computed tomography. 2012;6:246–51.

    Article  PubMed  Google Scholar 

  76. Tavris D, Shoaibi A, Chen AY, Uchida T, Roe MT, Chen J. Gender differences in the treatment of non-ST-segment elevation myocardial infarction. Clin Cardiol. 2010;33:99–103.

    Article  PubMed  Google Scholar 

  77. Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490–8.

    Article  PubMed  Google Scholar 

  78. Cho KI, Shin ES, Ann SH, et al. Gender differences in risk factors and clinical outcomes in young patients with acute myocardial infarction. J Epidemiol Community Health. 2016;70:1057–64.

    Article  PubMed  Google Scholar 

  79. Heer T, Hochadel M, Schmidt K, et al. Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology. Clinical research in cardiology: official journal of the German Cardiac Society. 2015;104:507–17.

    Article  Google Scholar 

  80. Johansen ME, Hefner JL, Foraker RE. Antiplatelet and statin use in US patients with coronary artery disease categorized by race/ethnicity and gender, 2003 to 2012. Am J Cardiol. 2015;115:1507–12.

    Article  PubMed  Google Scholar 

  81. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–304.

    Article  CAS  PubMed  Google Scholar 

  82. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006;295:306–13.

    Article  CAS  PubMed  Google Scholar 

  83. Antithrombotic Trialists C, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–60.

    Article  Google Scholar 

  84. Guirguis-Blake JM, Evans CV, Senger CA, O'Connor EA, Whitlock EP. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016;164:804–13.

    Article  PubMed  Google Scholar 

  85. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). International journal of behavioral medicine. 2012;19:403–88.

    Article  PubMed  Google Scholar 

  86. Mora S. Aspirin therapy in women: back to the ABCs. Circulation Cardiovascular quality and outcomes. 2009;2:63–4.

    Article  PubMed  Google Scholar 

  87. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;332:349–60.

  88. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59:572–82.

    Article  CAS  PubMed  Google Scholar 

  89. Cholesterol Treatment Trialists C, Fulcher J, O’Connell R, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397–405.

    Article  Google Scholar 

  90. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1–45.

    Article  PubMed  Google Scholar 

  91. Kumbhani DJ, Steg PG, Cannon CP, et al. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med. 2013;126:693–700. e1

    Article  PubMed  Google Scholar 

  92. Victor BM, Teal V, Ahedor L, Karalis DG. Gender differences in achieving optimal lipid goals in patients with coronary artery disease. Am J Cardiol. 2014;113:1611–5.

    Article  CAS  PubMed  Google Scholar 

  93. Writing C, Lloyd-Jones DM, Morris PB, et al. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2016;68:92–125.

    Article  Google Scholar 

  94. Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. The Cochrane database of systematic reviews. 2015;3:CD002229.

    Google Scholar 

  95. ACOG Committee Opinion No. 565: Hormone therapy and heart disease. Obstet Gynecol 2013;121:1407–1410.

  96. Colbert JD, Martin BJ, Haykowsky MJ, et al. Cardiac rehabilitation referral, attendance and mortality in women. Eur J Prev Cardiol. 2015;22:979–86.

    Article  PubMed  Google Scholar 

  97. Menezes AR, Lavie CJ, DeSchutter A, Milani RV. Gender, race and cardiac rehabilitation in the United States: is there a difference in care? The American journal of the medical sciences. 2014;348:146–52.

    Article  PubMed  Google Scholar 

  98. Johnson D, Sacrinty M, Mehta H, Douglas C, Paladenech C, Robinson K. Cardiac rehabilitation in African Americans: evidence for poorer outcomes compared with whites, especially in women and diabetic participants. Am Heart J. 2015;169:102–7.

    Article  PubMed  Google Scholar 

  99. Beckie TM, Fletcher G, Groer MW, Kip KE, Ji M. Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation. Journal of cardiopulmonary rehabilitation and prevention. 2015;35:103–13.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA

    Amy Sarma MD & Nandita S. Scott MD

Authors
  1. Amy Sarma MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nandita S. Scott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nandita S. Scott MD.

Ethics declarations

Conflict of Interest

Amy Sarma declares no potential conflicts of interest.

Nandita S. Scott is a section editor for Current Treatment Options in Cardiovascular Medicine.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Prevention

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarma, A., Scott, N.S. Assessing and Modifying Coronary Artery Disease Risk in Women. Curr Treat Options Cardio Med 19, 51 (2017). https://doi.org/10.1007/s11936-017-0554-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-017-0554-2

Keywords

Search

Navigation